TRIPALMITIN is a lipid of Glycerolipids (GL) class. Tripalmitin is associated with abnormalities such as Atherosclerosis, Hypoalphalipoproteinemias, Cystic Fibrosis, PARKINSON DISEASE, LATE-ONSET and Obesity. The involved functions are known as 5-(carboxyamino)imidazole ribonucleotide mutase activity, Certification, phosphatidylcholine-sterol O-acyltransferase activity, Regulation and Uptake. Tripalmitin often locates in Blood, Hepatic, Body tissue, Gastric mucosa and Biopsy sample. The associated genes with TRIPALMITIN are PON1 gene, very high density lipoproteins, THEMIS gene, HEPATIC PROTEIN and chylomicron remnant. The related lipids are Fatty Acids, Total cholesterol, Nonesterified Fatty Acids, Palmitates and tristearin.
To understand associated biological information of TRIPALMITIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
TRIPALMITIN is suspected in Atherosclerosis, Fatty Liver, Cystic Fibrosis, Hypoalphalipoproteinemias, PARKINSON DISEASE, LATE-ONSET, Obesity and other diseases in descending order of the highest number of associated sentences.
| Disease | Cross reference | Weighted score | Related literature |
|---|
We collected disease MeSH terms mapped to the references associated with TRIPALMITIN
| MeSH term | MeSH ID | Detail |
|---|---|---|
| HIV-Associated Lipodystrophy Syndrome | D039682 | 3 associated lipids |
| Respiratory Distress Syndrome, Newborn | D012127 | 5 associated lipids |
| Leishmaniasis, Visceral | D007898 | 13 associated lipids |
| Malabsorption Syndromes | D008286 | 16 associated lipids |
| Cystic Fibrosis | D003550 | 65 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
| Location | Cross reference | Weighted score | Related literatures |
|---|
| Function | Cross reference | Weighted score | Related literatures |
|---|
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
| Gene | Cross reference | Weighted score | Related literatures |
|---|
There are no associated biomedical information in the current reference collection.
| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Severino P et al. | Current State-of-Art and New Trends on Lipid Nanoparticles (SLN and NLC) for Oral Drug Delivery. | 2012 | J Drug Deliv | pmid:22175030 |
| Lopes R et al. | Lipid nanoparticles containing oryzalin for the treatment of leishmaniasis. | 2012 | Eur J Pharm Sci | pmid:21983568 |
| Yehia SA et al. | Biodegradable donepezil lipospheres for depot injection: optimization and in-vivo evaluation. | 2012 | J. Pharm. Pharmacol. | pmid:22943173 |
| Tsai MJ et al. | Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. | 2012 | Int J Pharm | pmid:22193056 |
| Nakahara H | [Study of novel artificial lung surfactants incorporating partially fluorinated amphiphiles]. | 2012 | Yakugaku Zasshi | pmid:22790027 |
| Vaidyanathan V et al. | Selective cannabinoid-1 receptor blockade benefits fatty acid and triglyceride metabolism significantly in weight-stable nonhuman primates. | 2012 | Am. J. Physiol. Endocrinol. Metab. | pmid:22761159 |
| Pal A et al. | Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis. | 2012 | J Liposome Res | pmid:21740098 |
| Patel MR and San Martin-Gonzalez MF | Characterization of ergocalciferol loaded solid lipid nanoparticles. | 2012 | J. Food Sci. | pmid:22260120 |
| Carilli J et al. | Historical temperature variability affects coral response to heat stress. | 2012 | PLoS ONE | pmid:22479626 |
| Witzleb R et al. | Dissolution of solid lipid extrudates in biorelevant media. | 2012 | Int J Pharm | pmid:22044538 |